These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 34806329)

  • 1. Multicenter Study of Utility and Acceptability of Depression and Anxiety Screening in Adolescents and Young Adults With Childhood-Onset Systemic Lupus.
    Rubinstein TB; Dionizovik-Dimanovski M; Davis AM; Smith C; Faust L; Rutstein B; Mitchell M; Jones JT; Harris JG; Rodriguez M; Tesher M; Onel K; Gabbay V; Stein REK; von Scheven E; Knight AM;
    Arthritis Care Res (Hoboken); 2023 Apr; 75(4):724-733. PubMed ID: 34806329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identifying clinically meaningful severity categories for PROMIS pediatric measures of anxiety, mobility, fatigue, and depressive symptoms in juvenile idiopathic arthritis and childhood-onset systemic lupus erythematosus.
    Mann CM; Schanberg LE; Wang M; von Scheven E; Lucas N; Hernandez A; Ringold S; Reeve BB
    Qual Life Res; 2020 Sep; 29(9):2573-2584. PubMed ID: 32410143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and pilot testing of the treatment and education approach for childhood-onset lupus (TEACH): a cognitive behavioral treatment.
    Cunningham NR; Fussner LM; Moorman E; Avar Aydin PO; Brunner HI; Kashikar-Zuck S
    Pediatr Rheumatol Online J; 2019 Feb; 17(1):9. PubMed ID: 30777090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Self-management and adherence in childhood-onset systemic lupus erythematosus: what are we missing?
    Harry O; Crosby LE; Smith AW; Favier L; Aljaberi N; Ting TV; Huggins JL; Modi AC
    Lupus; 2019 Apr; 28(5):642-650. PubMed ID: 30907294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of Patient-Reported Outcomes Measurement Information System Short Forms for Use in Childhood-Onset Systemic Lupus Erythematosus.
    Jones JT; Carle AC; Wootton J; Liberio B; Lee J; Schanberg LE; Ying J; Morgan DeWitt E; Brunner HI
    Arthritis Care Res (Hoboken); 2017 Jan; 69(1):133-142. PubMed ID: 27111350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of depressive and anxiety symptoms in childhood-onset systemic lupus erythematosus: Frequency, course, and associated risk factors.
    Neufeld KM; Moaf P; Quilter M; Danguecan AN; Couture J; Dominguez D; Hendrikx O; Ng L; Schachter R; Korczak DD; Levy DM; Hiraki L; Knight AM
    Lupus; 2024 Jul; 33(8):874-885. PubMed ID: 38774953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anxiety and depression symptoms in adolescents and young adults with juvenile idiopathic arthritis: results of an outpatient screening.
    Milatz F; Klotsche J; Niewerth M; Sengler C; Windschall D; Kallinich T; Dressler F; Trauzeddel R; Holl RW; Foeldvari I; Brück N; Temming S; Hospach T; Warschburger P; Berendes R; Erbis G; Kuemmerle-Deschner JB; Weller-Heinemann F; Haas JP; Müller-Stierlin AS; Mutter A; Meissner T; Baumeister H; Minden K
    Arthritis Res Ther; 2024 Apr; 26(1):82. PubMed ID: 38600543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-pharmacologic therapies in treatment of childhood-onset systemic lupus erythematosus: A systematic review.
    Ross E; Abulaban K; Kessler E; Cunningham N
    Lupus; 2022 Jun; 31(7):864-879. PubMed ID: 35442103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validity and Reliability of Patient Reported Outcomes Measurement Information System Computerized Adaptive Tests in Systemic Lupus Erythematosus.
    Kasturi S; Szymonifka J; Burket JC; Berman JR; Kirou KA; Levine AB; Sammaritano LR; Mandl LA
    J Rheumatol; 2017 Jul; 44(7):1024-1031. PubMed ID: 28412708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validity of the PROMIS depression and anxiety common metrics in an online sample of Australian adults.
    Sunderland M; Batterham P; Calear A; Carragher N
    Qual Life Res; 2018 Sep; 27(9):2453-2458. PubMed ID: 29872956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depressive symptoms are prevalent in childhood-onset systemic lupus erythematosus (cSLE).
    Kohut SA; Williams TS; Jayanthikumar J; Landolt-Marticorena C; Lefebvre A; Silverman E; Levy DM
    Lupus; 2013 Jun; 22(7):712-20. PubMed ID: 23704369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of self-report screening measures in the detection of depressive and anxiety disorders among children and adolescents with systemic lupus erythematosus.
    Quilter M; Hiraki L; Knight AM; Couture J; Levy D; Silverman ED; Danguecan AN; Ng L; Dominguez D; Cost KT; Neufeld KM; Schachter R; Korczak DJ
    Lupus; 2021 Jul; 30(8):1327-1337. PubMed ID: 34078154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Active implementation of low disease activity state as a treatment endpoint in childhood-onset systemic lupus erythematosus in routine practice is both feasible and associated with better outcomes.
    Gotch R; Ahmed Y; Wilson R; Hawkins E; Ciurtin C
    Clin Rheumatol; 2024 Oct; 43(10):3231-3238. PubMed ID: 39212796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of PROMIS® to screen for depression in children with arthritis.
    Yan Y; Rychlik KL; Rosenman MB; Miller ML
    Pediatr Rheumatol Online J; 2020 Nov; 18(1):92. PubMed ID: 33228749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What Proportion of Patients With Musculoskeletal Sarcomas Demostrate Symptoms of Depression or Anxiety?
    Polfer EM; Alici Y; Baser RE; Healey JH; Bartelstein MK
    Clin Orthop Relat Res; 2022 Nov; 480(11):2148-2160. PubMed ID: 35901433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Depression and anxiety and their association with healthcare utilization in pediatric lupus and mixed connective tissue disease patients: a cross-sectional study.
    Knight A; Weiss P; Morales K; Gerdes M; Gutstein A; Vickery M; Keren R
    Pediatr Rheumatol Online J; 2014; 12():42. PubMed ID: 25242900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An exploration of patient-reported symptoms in systemic lupus erythematosus and the relationship to health-related quality of life.
    Pettersson S; Lövgren M; Eriksson LE; Moberg C; Svenungsson E; Gunnarsson I; Welin Henriksson E
    Scand J Rheumatol; 2012 Oct; 41(5):383-90. PubMed ID: 22646821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fatigue, patient reported outcomes, and objective measurement of physical activity in systemic lupus erythematosus.
    Mahieu MA; Ahn GE; Chmiel JS; Dunlop DD; Helenowski IB; Semanik P; Song J; Yount S; Chang RW; Ramsey-Goldman R
    Lupus; 2016 Oct; 25(11):1190-9. PubMed ID: 26869353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Responsiveness of the PROMIS® measures to changes in disease status among pediatric nephrotic syndrome patients: a Midwest pediatric nephrology consortium study.
    Selewski DT; Troost JP; Cummings D; Massengill SF; Gbadegesin RA; Greenbaum LA; Shatat IF; Cai Y; Kapur G; Hebert D; Somers MJ; Trachtman H; Pais P; Seifert ME; Goebel J; Sethna CB; Mahan JD; Gross HE; Herreshoff E; Liu Y; Carlozzi NE; Reeve BB; DeWalt DA; Gipson DS
    Health Qual Life Outcomes; 2017 Aug; 15(1):166. PubMed ID: 28835233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construct validity of Patient-Reported Outcomes Measurement Information System Paediatric measures in juvenile idiopathic arthritis and systemic lupus erythematosus: cross-sectional evaluation.
    Weitzman ER; Gaultney A; von Scheven E; Ringold S; Mann CM; Magane KM; Lin L; Leverty R; Dennos A; Hernandez A; Lippmann SJ; Dedeoglu F; Marin AC; Cox R; Reeve BB; Schanberg LE
    BMJ Open; 2023 Jan; 13(1):e063675. PubMed ID: 36707118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.